RNF113B
gene geneOn this page
Also known as RNF161
Summary
RNF113B (ring finger protein 113B, HGNC:17267) is a protein-coding gene on chromosome 13q32.2, encoding RING finger protein 113B (Q8IZP6).
Predicted to enable zinc ion binding activity. Predicted to be involved in snoRNA splicing. Predicted to be part of U2-type spliceosomal complex.
Source: NCBI Gene 140432 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- MANE Select transcript:
NM_178861
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17267 |
| Approved symbol | RNF113B |
| Name | ring finger protein 113B |
| Location | 13q32.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RNF161 |
| Ensembl gene | ENSG00000139797 |
| Ensembl biotype | protein_coding |
| Entrez | 140432 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000267291
RefSeq mRNA: 1 — MANE Select: NM_178861
NM_178861
CCDS: CCDS9486
Canonical transcript exons
ENST00000267291 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000940222 | 98176282 | 98177269 |
| ENSE00001373481 | 98175785 | 98176176 |
Expression profiles
Bgee: expression breadth broad, 29 present calls, max score 90.50.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1374 / max 121.3419, expressed in 6 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 137914 | 0.1120 | 4 |
| 137913 | 0.0254 | 4 |
Top tissues by expression
108 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 90.50 | gold quality |
| testis | UBERON:0000473 | 90.09 | gold quality |
| right testis | UBERON:0004534 | 89.59 | gold quality |
| quadriceps femoris | UBERON:0001377 | 84.52 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.73 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.71 | gold quality |
| cerebellar vermis | UBERON:0004720 | 75.34 | gold quality |
| adrenal tissue | UBERON:0018303 | 59.31 | gold quality |
| thymus | UBERON:0002370 | 58.79 | silver quality |
| calcaneal tendon | UBERON:0003701 | 49.51 | silver quality |
| colonic epithelium | UBERON:0000397 | 48.18 | silver quality |
| liver | UBERON:0002107 | 45.20 | silver quality |
| kidney | UBERON:0002113 | 42.82 | silver quality |
| tonsil | UBERON:0002372 | 42.66 | gold quality |
| blood | UBERON:0000178 | 42.28 | silver quality |
| right lobe of liver | UBERON:0001114 | 42.27 | silver quality |
| prostate gland | UBERON:0002367 | 42.11 | gold quality |
| bone marrow cell | CL:0002092 | 40.56 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 40.52 | gold quality |
| monocyte | CL:0000576 | 40.20 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 39.98 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 39.77 | gold quality |
| leukocyte | CL:0000738 | 39.60 | gold quality |
| bone marrow | UBERON:0002371 | 39.05 | gold quality |
| cortex of kidney | UBERON:0001225 | 38.40 | silver quality |
| adrenal gland | UBERON:0002369 | 37.43 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.34 | gold quality |
| muscle tissue | UBERON:0002385 | 37.10 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 37.05 | silver quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.78 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
11 targeting RNF113B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-12130 | 99.75 | 65.47 | 452 |
| HSA-MIR-6734-3P | 99.15 | 66.27 | 1627 |
| HSA-MIR-758-3P | 98.42 | 68.60 | 1122 |
| HSA-MIR-876-5P | 97.99 | 68.49 | 1345 |
| HSA-MIR-510-5P | 97.66 | 65.82 | 916 |
| HSA-MIR-3167 | 96.81 | 67.09 | 1236 |
| HSA-MIR-550B-3P | 95.43 | 67.73 | 599 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rnf113a | ENSDARG00000037930 |
| drosophila_melanogaster | mdlc | FBGN0038772 |
| caenorhabditis_elegans | WBGENE00010476 |
Paralogs (1): RNF113A (ENSG00000125352)
Protein
Protein identifiers
RING finger protein 113B — Q8IZP6 (reviewed: Q8IZP6)
Alternative names: Zinc finger protein 183-like 1
All UniProt accessions (1): Q8IZP6
RefSeq proteins (1): NP_849192* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000571 | Znf_CCCH | Domain |
| IPR001841 | Znf_RING | Domain |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR017907 | Znf_RING_CS | Conserved_site |
| IPR036855 | Znf_CCCH_sf | Homologous_superfamily |
| IPR039971 | CWC24-like | Family |
Pfam: PF00642, PF13920
UniProt features (13 total): strand 4, zinc finger region 2, helix 2, chain 1, region of interest 1, compositionally biased region 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2CSY | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IZP6-F1 | 72.66 | 0.31 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 16 (showing top):
GOBP_RNA_SPLICING, chr13q32, GOCC_U2_TYPE_SPLICEOSOMAL_COMPLEX, GOCC_SPLICEOSOMAL_COMPLEX, GOCC_RIBONUCLEOPROTEIN_COMPLEX, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOBP_MRNA_PROCESSING, MIR6867_5P, MIR450B_5P, MIR758_3P, GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX, GOBP_MRNA_METABOLIC_PROCESS, GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP, GOBP_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS
GO Biological Process (1): snoRNA splicing (GO:0034247)
GO Molecular Function (2): zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (1): U2-type spliceosomal complex (GO:0005684)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA splicing | 1 |
| sno(s)RNA processing | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| spliceosomal complex | 1 |
Protein interactions and networks
STRING
1475 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RNF113B | FARP1 | Q9Y4F1 | 571 |
| RNF113B | DCAF12 | Q5T6F0 | 542 |
| RNF113B | DCAF12L2 | Q5VW00 | 475 |
| RNF113B | ZIC5 | Q96T25 | 447 |
| RNF113B | DOCK9 | Q9BZ29 | 447 |
| RNF113B | TRIM74 | Q86UV6 | 432 |
| RNF113B | POM121L2 | Q96KW2 | 418 |
| RNF113B | TRIM73 | Q86UV7 | 417 |
| RNF113B | UBAC2 | Q8NBM4 | 414 |
| RNF113B | TMEM278 | A6NKF7 | 400 |
| RNF113B | UGGT2 | Q9NYU1 | 390 |
| RNF113B | CYB5D1 | Q6P9G0 | 382 |
| RNF113B | RFPL4A | A6NLU0 | 376 |
| RNF113B | RNF141 | Q8WVD5 | 372 |
| RNF113B | TRIML1 | Q8N9V2 | 370 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RNF113B | H1-4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| RNF113B | UBE2L3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| UBE2R2 | RNF113B | psi-mi:“MI:0915”(physical association) | 0.370 |
| RNF113B | UBE2H | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (9): RNF113B (Co-fractionation), RNF113B (Proximity Label-MS), GIT1 (Affinity Capture-MS), RNF113A (Affinity Capture-MS), RNF113B (Proximity Label-MS), RNF113B (Two-hybrid), RNF113B (Two-hybrid), RNF113B (Two-hybrid), RNF113B (Two-hybrid)
ESM2 similar proteins: A2XIP9, A5GFW7, B1WB17, B4FGS2, E1C760, E7EXT2, F7AEX0, O15541, O59800, P0CR50, P0CR51, P28518, P35251, P35600, P35601, P35728, P52012, Q0VCR1, Q10154, Q21755, Q28E45, Q2R2B4, Q3LSS0, Q3T1J8, Q4P400, Q4R594, Q5AX35, Q5AXT6, Q5EAW4, Q5FVF1, Q5R9P9, Q5ZJN1, Q640E9, Q67ER4, Q6C3L4, Q70Z53, Q75LU5, Q810J8, Q8BP78, Q8IZP6
Diamond homologs: O15541, O17917, P0CQ64, P0CQ65, P53769, Q02398, Q1JPS1, Q4P400, Q4WUA0, Q55G16, Q5ACW2, Q5AVC5, Q67ER4, Q6BYU0, Q6CB23, Q6CSS6, Q6FXX1, Q6K4V3, Q752S4, Q7SDY3, Q8GX84, Q8IZP6, Q9FNG6, Q9P6R8, Q03605, O74747, G2Q0E2, P33288, Q1XHU0, Q6FPI4, Q6MFZ5, Q75EN0, Q7ZWF4, Q9ESN2, Q9HCM9, A0A3B3IT33, A4QPC6, A6NCK2, A6NDI0, A6NGJ6
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | RNF113B | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
87 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 13:98176274:G:A | donor_gain | 0.9300 |
| 13:98176278:CCACC:C | donor_loss | 0.9300 |
| 13:98176279:CACC:C | donor_loss | 0.9300 |
| 13:98176280:ACC:A | donor_loss | 0.9300 |
| 13:98176276:CCCCA:C | donor_loss | 0.9200 |
| 13:98176277:CCCAC:C | donor_loss | 0.9200 |
| 13:98176491:T:TA | donor_gain | 0.9200 |
| 13:98176485:T:TA | donor_gain | 0.9000 |
| 13:98176281:CCTT:C | donor_gain | 0.8800 |
| 13:98176282:C:G | donor_loss | 0.8700 |
| 13:98176178:T:A | acceptor_loss | 0.7600 |
| 13:98176290:G:GA | donor_gain | 0.7600 |
| 13:98176177:C:CC | acceptor_gain | 0.6900 |
| 13:98176289:AG:A | donor_gain | 0.6600 |
| 13:98176172:TTTTC:T | acceptor_gain | 0.6200 |
| 13:98176175:TC:T | acceptor_gain | 0.6200 |
| 13:98176176:CC:C | acceptor_gain | 0.6200 |
| 13:98176174:TTC:T | acceptor_gain | 0.6100 |
| 13:98176506:T:TA | donor_gain | 0.6000 |
| 13:98176186:C:CT | acceptor_gain | 0.5700 |
| 13:98176667:A:AG | donor_gain | 0.5700 |
| 13:98176499:T:TA | donor_gain | 0.5600 |
| 13:98176500:C:A | donor_gain | 0.5600 |
| 13:98176274:GCCC:G | donor_loss | 0.5300 |
| 13:98176275:CCCC:C | donor_loss | 0.5300 |
| 13:98176277:C:T | donor_gain | 0.5300 |
| 13:98176283:T:C | donor_loss | 0.5300 |
| 13:98176173:TTTC:T | acceptor_gain | 0.5200 |
| 13:98176273:TGCCC:T | donor_loss | 0.5100 |
| 13:98176177:C:T | acceptor_gain | 0.4900 |
AlphaMissense
2135 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 13:98176598:G:C | F213L | 0.988 |
| 13:98176598:G:T | F213L | 0.988 |
| 13:98176600:A:G | F213L | 0.988 |
| 13:98176412:G:C | F275L | 0.986 |
| 13:98176412:G:T | F275L | 0.986 |
| 13:98176414:A:G | F275L | 0.986 |
| 13:98176437:A:T | V267D | 0.985 |
| 13:98176616:G:C | F207L | 0.985 |
| 13:98176616:G:T | F207L | 0.985 |
| 13:98176618:A:G | F207L | 0.985 |
| 13:98176646:C:A | K197N | 0.968 |
| 13:98176646:C:G | K197N | 0.968 |
| 13:98176368:C:G | C290S | 0.964 |
| 13:98176369:A:T | C290S | 0.964 |
| 13:98176448:G:C | F263L | 0.964 |
| 13:98176448:G:T | F263L | 0.964 |
| 13:98176450:A:G | F263L | 0.964 |
| 13:98176625:G:C | F204L | 0.964 |
| 13:98176625:G:T | F204L | 0.964 |
| 13:98176627:A:G | F204L | 0.964 |
| 13:98176335:A:G | F301S | 0.963 |
| 13:98176413:A:C | F275C | 0.962 |
| 13:98176413:A:G | F275S | 0.962 |
| 13:98176334:A:C | F301L | 0.960 |
| 13:98176334:A:T | F301L | 0.960 |
| 13:98176336:A:G | F301L | 0.960 |
| 13:98176425:C:G | C271S | 0.956 |
| 13:98176426:A:T | C271S | 0.956 |
| 13:98176418:A:C | H273Q | 0.955 |
| 13:98176418:A:T | H273Q | 0.955 |
dbSNP variants (sampled 300 via entrez): RS1000721301 (13:98177587 T>C), RS1002496351 (13:98175821 G>A,C), RS1003170212 (13:98178884 A>G,T), RS1003229314 (13:98179080 T>C), RS1006035214 (13:98177889 A>G), RS1006443207 (13:98176961 C>A,T), RS1007297013 (13:98176684 C>T), RS1009588146 (13:98175702 C>T), RS1009704630 (13:98175347 A>C), RS1014348290 (13:98175885 G>T), RS1017220859 (13:98179131 A>G), RS1018161527 (13:98177113 C>A,G,T), RS1018784426 (13:98178091 A>T), RS1020678119 (13:98175415 TATCCTTTATTTGCTGTTTTGGTAACTCTTGAACCCC>T), RS1022394689 (13:98175369 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002595_23 | Clozapine-induced agranulocytosis | 8.000000e-06 |
| GCST009391_2024 | Metabolite levels | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010371 | lysophosphatidylethanolamine 22:6 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Paraoxon | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.